Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-06

Clinical Trial Update: Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of methylphenidate in children with Attention Deficit Hyperactivity Disorder has completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate (Methylphenidate)

Snippet

Sponsor: Novartis | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: COMPLETED | Results posted: 2011-05-06